A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
Pliant Therapeutics, Inc.
Henan Cancer Hospital
Institut Paoli-Calmettes
Centre Hospitalier Universitaire Vaudois
Activ Surgical
Zhejiang University
Shantou University Medical College
Aurigene Discovery Technologies Limited
Sun Yat-sen University
RenJi Hospital
Xijing Hospital
Case Comprehensive Cancer Center
Chongqing Precision Biotech Co., Ltd
Sun Yat-sen University
University Hospital, Ghent
Fujian Medical University Union Hospital
National Taiwan University Hospital
Massachusetts General Hospital
Fuling Central Hospital of Chongqing City
Sun Yat-sen University
Assaf-Harofeh Medical Center
Fudan University
Azienda Sanitaria-Universitaria Integrata di Udine
Zuyderland Medisch Centrum
Johann Wolfgang Goethe University Hospital
Kineta Inc.
Universitätsklinikum Hamburg-Eppendorf
National Cheng-Kung University Hospital
Fox Chase Cancer Center
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
China Medical University, Taiwan
Capsulomics, Inc.
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Royal Marsden NHS Foundation Trust
Chang Gung Memorial Hospital
Sohag University
Louis Stokes VA Medical Center
Karolinska University Hospital
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
University of Cape Town
Imperial College London
ImmVira Pharma Co. Ltd
Ruijin Hospital
Chongqing Precision Biotech Co., Ltd
Revolution Medicines, Inc.
Tianjin Medical University Cancer Institute and Hospital
Jiangsu Cancer Institute & Hospital
Tianjin Medical University Cancer Institute and Hospital
University Medical Center Ho Chi Minh City (UMC)